08.18.2018 Issue 135

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Data Analyst II – Real-World Evidence (flexible location)

The Real-World Evidence team supports biopharmaceutical companies throughout the product lifecycle, from early pre-launch planning to launch and post-marketing management.

Senior Director, HEOR Oncology and Specialty

Adjunct Faculty, Economics of Health Care, online

Watson Health - Lead Research Analyst (Outcomes Research)

Watson Health - Senior SAS Programmer Analyst (Medical and healthcare claims data)

Watson Health - Statistician/ Sr Statistician (HEOR/medical claims data)

Watson Health - Outcomes Researcher

Senior Principal - Health Economics

Principal - HTA

Principal, Health Economics


Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

U.K. Wants Price Controls Applied to Biosimilars

Improving MACRA’s Quality Payment Program, MIPS

Report: Eli Lilly Ignoring California’s Price Hike Notice Law

Article: AI at ‘Forefront of Healthcare Revolution’

Trump Administration Closes Medicaid Loophole on Drug Rebates

Vertex Pharmaceuticals Continues to Spar with U.K. Government

Express Scripts Blocks 48 Drugs

Industry Spotlight



Conferences Webinars
World Congress on Biosensors and Bioelectronics
    August 20-21, Chicago, Illinois

340B Manufacturer Summit
    August 21-22, Washington, D.C.

Bio/Pharma Forum on the State of Medicare Reform
    August 21, Arlington, Virginia

4th Annual PBM Contracting: Methodologies for Contract Innovations
    August 22-23, Chicago, Illinois

6th Annual Real-World Analytics Summit 2018
    September 1-2, Boston, Massachusetts

The Next Generation PSP: How to Maximize Patient Outcomes and Boost Patient Experience Through More Advance PSP Design
    August 30

PROving Its Worth: How to Develop a PRO Strategy to Distinguish Your Product with Regulators and Payers
    September 12

Using Real World Evidence in the Real World Oncology Practice Setting
    September 19

Beyond Controlling for Confounding: Design Strategies to Avoid Selection Bias and Improve Efficiency in Observational Studies
    September 27


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Blockchain: Transformational Change for Pharma?

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

HTA in Europe: Key Success Factors for Positive HTA Recommendations

Paying for Digital Health: Payer Insights

Benchmarking Pharma’s MSL Capabilities

Biosimilars: U.S. Payer Perspectives

KAM Metrics: Driving Efficiency, Measuring Success

A Holistic Approach to Payment Accuracy Helps Drive Cost Savings

Improving Patient Matching with a Simple Plug-In

Real-World Evidence in the Cloud: How Technology is Revealing the Big Picture in Pharma

How Payers Can Save an Average of $25,579 Per Patient by Eliminating Unwarranted, Non-Evidence-Based Cancer Treatment

ICER’s Reference Case for Economic Evaluations: Principles and Rationale

A Guide to Getting Started in HEOR/Market Access Medical Writing


Special Thanks to Our Partners:
         Evidera   HealthCore     University of FL   Truven
      Xcenda  OM1    Parexel   Jefferson   Dymaxium
      Precision Xtract    Pharmerit    eMax Health   Sciformix
      Evidence Partners    ICON